BB vs PTGX · P/E 117, rev $549.1M vs rev $269.8M
BlackBerry Ltd (BB) versus Protagonist Therapeutics Inc (PTGX) — a side-by-side from cached financials, not a winner call.
BlackBerry Ltd (BB) is a software - infrastructure company listed on US.
Protagonist Therapeutics Inc (PTGX) is a biotechnology company listed on NASDAQ.
Latest reported BB revenue for 2026-02-28 was $549.1M. Net income was $53.2M. Revenue was up 2.7% from 2025-02-28 to 2026-02-28. BB currently screens at market cap $6.14B and trailing P/E 116.5.
Latest reported PTGX revenue for 2026-06-30 was $269.8M. Net income was $166.6M. PTGX currently screens at market cap $7.25B.
BB currently screens at market cap $6.14B and trailing P/E 116.5. PTGX currently screens at market cap $7.25B.
Not investment advice. Open the BB and PTGX stock pages for the full models.
Not investment advice.